• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. GYNECARE MORCELLEX UNKNOWN PRODUCT; LAPARSCOPE, GYNECOLOGIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. GYNECARE MORCELLEX UNKNOWN PRODUCT; LAPARSCOPE, GYNECOLOGIC Back to Search Results
Device Problem Other (for use when an appropriate device code cannot be identified) (2203)
Patient Problems Surgical procedure (2357); Iatrogenic Source (2498); Treatment with medication(s) (2571)
Event Date 04/04/2013
Event Type  Injury  
Event Description
It was reported by an attorney that the patient underwent a laparoscopic surgical procedure to remove uterine fibroids on (b)(6) 2013 and the diva morcellex was utilized.It was reported that following the surgery, the patient was diagnoses with leiomyosarcoma, and has undergone aggressive treatment and therapy to treat the cancer.No additional information was provided.
 
Manufacturer Narrative
(b)(4).Conclusion: the device information for use under precautions states" caution: the use of a laparoscopic tissue extraction bag is recommended for the morcellation of malignant tissue or tissue suspected of being malignant and for tissue that the physician considers to be potentially harmful when disseminated in a body cavity.As morcellation may affect endometrial pathologic examination, preoperative evaluation of the endometrium should be considered.Should malignancy be identified, use of the gynecare morcellex¿ tissue morcellator may lead to dissemination of malignant tissue.
 
Manufacturer Narrative
It was reported that following the (b)(6) 2013 surgery, pathology reported the myometrium with a smooth muscle tumor of uncertain malignant potential.On (b)(6) 2014 she had a radical optimal tumor debulking, trachelectomy via laparotomy.Leiomyosarcoma was diagnoised on unk date and chemotherapy x6 on (b)(6) 2015.On (b)(6) 2015 she had a debulking of a pelvic mass.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GYNECARE MORCELLEX UNKNOWN PRODUCT
Type of Device
LAPARSCOPE, GYNECOLOGIC
Manufacturer (Section D)
ETHICON INC.
p.o. box 151, route 22 west
somerville NJ 08876 0151
Manufacturer (Section G)
MEDTECH GROUP INC
6 century ln
south plainfield NJ 07080
Manufacturer Contact
guillermo villa
route 22 west po box 151
somerville, NJ 08876
9082180707
MDR Report Key4720491
MDR Text Key16309776
Report Number2210968-2015-04873
Device Sequence Number1
Product Code HET
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K100280
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,other
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 04/17/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/22/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? No
Date Manufacturer Received01/29/2016
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age61 YR
Patient Weight57
-
-